Concepedia

Kimberly E. Fultz

KE

Statistics

Publications

11

Citations

614

H-Index

11

Active since

2001

Affiliations

University of Arizona(Current)

Bristol-Myers Squibb (Switzerland)

Kimberly E. Fultz is an author at University of Arizona specializing in pharmacology, kinase inhibitors, and drug discovery.

Publications per year

2001–2019

11

Publications

11

Pronounced reduction in adenoma recurrence associated with aspirin use and a polymorphism in the ornithine decarboxylase gene

Marı́a Elena Martı́nez, Thomas G. O’Brien, Kimberly E. Fultz et al. · Proceedings of the National Academy of Sciences · 2003 · 197 citations · Full text

, , +16

Optimization of a Series of Triazole Containing Mammalian Target of Rapamycin (mTOR) Kinase Inhibitors and the Discovery of CC-115

Deborah S. Mortensen, Sophie Perrin-Ninkovic, Graziella Shevlin et al. · Journal of Medicinal Chemistry · 2015 · 73 citations · Full text

, , +14

Inhibition of Tumor Growth, Angiogenesis, and Tumor Cell Proliferation by a Small Molecule Inhibitor of c-Jun N-terminal Kinase

Bruce W. Ennis, Kimberly E. Fultz, John Westwick et al. · Journal of Pharmacology and Experimental Therapeutics · 2005 · 69 citations

, , +15

CC-223, a Potent and Selective Inhibitor of mTOR Kinase: <i>In Vitro</i> and <i>In Vivo</i> Characterization

Deborah S. Mortensen, Kimberly E. Fultz, Shuichan Xu et al. · Molecular Cancer Therapeutics · 2015 · 53 citations · Full text

, , +14

APC‐dependent regulation of ornithine decarboxylase in human colon tumor cells

Kimberly E. Fultz, Eugene W. Gerner · Molecular Carcinogenesis · 2002 · 49 citations

, , +17

1–5 of 11